Normal	O
Levels	O
of	O
Sox9	O
Expression	O
in	O
the	O
Developing	O
Mouse	O
Testis	O
Depend	O
on	O
the	O
TES	S-ENHANCER
/	O
TESCO	B-ENHANCER
Enhancer	E-ENHANCER
,	O
but	O
This	O
Does	O
Not	O
Act	O
Alone	O
.	O


During	O
mouse	O
sex	O
determination	O
,	O
transient	O
expression	O
of	O
the	O
Y	O
-	O
linked	O
gene	O
Sry	O
up	O
-	O
regulates	O
its	O
direct	O
target	O
gene	O
Sox9	O
,	O
via	O
a	O
3	B-ENHANCER
.	I-ENHANCER
2	I-ENHANCER
kb	I-ENHANCER
testis	I-ENHANCER
specific	I-ENHANCER
enhancer	I-ENHANCER
of	I-ENHANCER
Sox9	E-ENHANCER
(	O
TES	S-ENHANCER
)	O
,	O
which	O
includes	O
a	O
core	B-ENHANCER
1	I-ENHANCER
.	I-ENHANCER
4	I-ENHANCER
kb	I-ENHANCER
element	I-ENHANCER
,	I-ENHANCER
TESCO	E-ENHANCER
.	O


SOX9	O
activity	O
leads	O
to	O
differentiation	O
of	O
Sertoli	O
cells	O
,	O
rather	O
than	O
granulosa	O
cells	O
from	O
the	O
bipotential	O
supporting	O
cell	O
precursor	O
lineage	O
.	O


Here	O
,	O
we	O
present	O
functional	O
analysis	O
of	O
TES	S-ENHANCER
/	O
TESCO	S-ENHANCER
,	O
using	O
CRISPR	O
/	O
Cas9	O
genome	O
editing	O
in	O
mice	O
.	O


Deletion	O
of	O
TESCO	S-ENHANCER
or	O
TES	S-ENHANCER
reduced	O
Sox9	O
expression	O
levels	O
in	O
XY	O
fetal	O
gonads	O
to	O
60	O
or	O
45	O
%	O
respectively	O
relative	O
to	O
wild	O
type	O
gonads	O
,	O
and	O
reduced	O
expression	O
of	O
the	O
SOX9	O
target	O
Amh	O
.	O


Although	O
human	O
patients	O
heterozygous	O
for	O
null	O
mutations	O
in	O
SOX9	O
,	O
which	O
are	O
assumed	O
to	O
have	O
50	O
%	O
of	O
normal	O
expression	O
,	O
often	O
show	O
XY	O
female	O
sex	O
reversal	O
,	O
mice	O
deleted	O
for	O
one	O
copy	O
of	O
Sox9	O
do	O
not	O
.	O


Consistent	O
with	O
this	O
,	O
we	O
did	O
not	O
observe	O
sex	O
reversal	O
in	O
either	O
TESCO	S-ENHANCER
-	O
/	O
-	O
or	O
TES	S-ENHANCER
-	O
/	O
-	O
XY	O
embryos	O
or	O
adult	O
mice	O
.	O


However	O
,	O
embryos	O
carrying	O
both	O
a	O
conditional	O
Sox9	O
null	O
allele	O
and	O
the	O
TES	S-ENHANCER
deletion	O
developed	O
ovotestes	O
.	O


Quantitative	O
analysis	O
of	O
these	O
revealed	O
levels	O
of	O
23	O
%	O
expression	O
of	O
Sox9	O
compared	O
to	O
wild	O
type	O
,	O
and	O
a	O
significant	O
increase	O
in	O
the	O
expression	O
of	O
the	O
granulosa	O
cell	O
marker	O
Foxl2	O
.	O


This	O
indicates	O
that	O
the	O
threshold	O
in	O
mice	O
where	O
sex	O
reversal	O
begins	O
to	O
be	O
seen	O
is	O
about	O
half	O
that	O
of	O
the	O
~	O
50	O
%	O
levels	O
predicted	O
in	O
humans	O
.	O


Our	O
results	O
demonstrate	O
that	O
TES	S-ENHANCER
/	O
TESCO	S-ENHANCER
is	O
a	O
crucial	O
enhancer	S-ENHANCER
regulating	O
Sox9	O
expression	O
in	O
the	O
gonad	O
,	O
but	O
point	O
to	O
the	O
existence	O
of	O
additional	O
enhancers	O
that	O
act	O
redundantly	O
.	O
